Exchange Traded Concepts’s BioTelemetry, Inc. BEAT Stock Holding History

Exchange Traded Concepts’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-24,822	Closed	-$1.79M	–	1209
2020 Q4	$1.79M	Buy	24,822 +9,669	+64%	+$506K	0.08%	165
2020 Q3	$691K	Buy	15,153 +8,817	+139%	+$369K	0.04%	220
2020 Q2	$286K	Buy	6,336 +3,117	+97%	+$140K	0.05%	400
2020 Q1	$124K	Buy	3,219 +1,532	+91%	+$70.5K	0.07%	242
2019 Q4	$78K	Buy	+1,687	New	+$73.1K	0.02%	231

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Exchange Traded Concepts's BEAT Position: Q1 2021 in Review

Exchange Traded Concepts sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 24,822 shares — an estimated $1.79M sold.

Exchange Traded Concepts first reported a position in BEAT in Q4 2019 and held it in 5 quarters. The position peaked at $1.79M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Exchange Traded Concepts reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Exchange Traded Concepts sold 24,822 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.79M.
Exchange Traded Concepts first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 5 quarters.
Exchange Traded Concepts's BioTelemetry, Inc. position peaked at $1.79M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Exchange Traded Concepts's 13F filing for Q1 2021, filed 20 Apr 2021.